Skip to main content

We’re not only bridging the barrier between mind and body, but we’re also making headlines with our innovative digital therapeutics.

PRESS RELEASES AND ANNOUNCEMENTS

metaMe Health Gains Worldwide Licensing Rights to Gut-Directed Hypnotherapy Protocol for Functional Dyspepsia

Agreement with Dr. Sarah Kinsinger and Dr. Olafur Palsson gives metaMe Health global rights to develop and market the digital therapeutic Functional… Read more

metaMe Health Named to the 2022 CB Insights Digital Health Top 150 List

CHICAGO, December 9, 2022 – metaMe Health breaks into the top 150 of the most promising private digital health companies of 2022. By being recognized… Read more

metaMe Health partners with Launchit Ventures to market Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with IBS, in Canada

metaMe Health licenses rights to commercialization of Regulora® in Canada to Launchit Ventures, Inc. to expedite the availability of Regulora… Read more


COMPANY AND INDUSTRY NEWS

To better understand gastropsychology, Healio Gastroenterology spoke with experts about its place in a patient’s care plan, how to implement it into… Read more

Listen to UNC-Chapel Hill’s Dr. Olafur Palsson, originator of the gold-standard North Carolina treatment protocol for gut-directed hypnotherapy (GDH)… Read more

Hear metaMe Health CEO Tim Rudolphi discuss the founding story of our company, the impact of gut-directed hypnotherapy, and the commercialization of PDTs. Listen… Read more

STAY CONNECTED TO THE FUTURE OF
PRESCRIPTION DIGITAL THERAPIES

Join our mailing list: